Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients
Open accessAbstract
Background—: Despite a recent American Heart Association (AHA) consensus statement emphasizing the importance of resistant hypertension, the incidence and prognosis of this condition are largely unknown. Methods and Results—: This retrospective cohort study in 2 integrated health plans included patients with incident hypertension in whom treatment was begun between 2002 and 2006. Patients were followed up for the development of resistant hypertension based on AHA criteria of uncontrolled blood pressure despite use of ≥3 antihypertensive medications, with data collected on prescription filling information and blood pressure measurement. We determined incident cardiovascular events (death or incident myocardial infarction, heart failure, stroke, or chronic kidney disease) in patients with and without resistant hypertension with adjustment for patient and clinical characteristics. Among 205 750 patients with incident hypertension, 1.9% developed resistant hypertension within a median of 1.5 years from initial treatment (0.7 cases per 100 person-years of follow-up). These patients were more often men, were older, and had higher rates of diabetes mellitus than nonresistant patients. Over 3.8 years of median follow-up, cardiovascular event rates were significantly higher in those with resistant hypertension (unadjusted 18.0% versus 13.5%, P <0.001). After adjustment for patient and clinical characteristics, resistant hypertension was associated with a higher risk of cardiovascular events (hazard ratio, 1.47; 95% confidence interval, 1.33–1.62). Conclusions—: Among patients with incident hypertension in whom treatment was begun, 1 in 50 patients developed resistant hypertension. Patients with resistant hypertension had an increased risk of cardiovascular events, which supports the need for greater efforts toward improving hypertension outcomes in this population.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In a retrospective study of more than 200,000 patients with incident hypertension, those with resistant hypertension were 47% more likely to suffer the combined outcomes of death, myocardial infarction, heart failure, stroke, or chronic kidney disease over the median 3.8 years of follow-up.
“In a retrospective study of >200 000 patients with incident hypertension, those with RH were 47% more likely to suffer the combined outcomes of death, myocardial infarction, heart failure, stroke, or CKD over the median 3.8 years of follow-up.23”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [23]
Resistant hypertension is associated with an increased risk of adverse outcomes compared with non-resistant hypertension.
“The importance of RH is underscored by the associated risk of adverse outcomes compared with non-RH.”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [23]
In that retrospective study, differences in cardiovascular disease events were driven largely by a higher risk for the development of chronic kidney disease.
“Differences in CVD events in this study were driven largely by a higher risk for the development of CKD.23”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [23]
The higher prevalence of apparent treatment-resistant hypertension among treated hypertensive adults in clinical trials (34%-39%) is likely explained by the selection of patients with demographic and comorbidity characteristics that place them at high risk for the fatal and nonfatal cardiovascular disease outcomes of interest.
“The higher prevalence of aTRH among treated hypertensive adults in clinical trials (34%−39%) is likely explained by the selection of patients with demographic and comorbidity characteristics that place them at high risk for the fatal and nonfatal CVD outcomes of interest.21–26”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271 · see citing works
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026 · see citing works
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y., Hendriksen, S. M., Kusek, J. W., & Lente, F. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,726 · see citing works
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407 · see citing works
Hajjar, I. M. (2003) · JAMA · doi:10.1001/jama.290.2.199 · Cited by 2,399 · see citing works
Global burden of blood-pressure-related disease, 2001
Lawes, C. M. M., Hoorn, S. V., & Rodgers, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60655-8 · Cited by 2,314 · see citing works
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
Calhoun, D. A., Jones, D. W., Textor, S. C., Goff, D. C., Murphy, T. P., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Sica, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,232 · see citing works
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2000) · JAMA · doi:10.1001/jama.283.15.1967 · Cited by 1,553 · see citing works
Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448 · see citing works
Pepine, C. J., Handberg, E. M., Cooper‐DeHoff, R. M., Marks, R. G., Kowey, P. R., Messerli, F. H., Mancia, G., Cangiano, J. L., García-Barreto, D., Keltai, M., et al. (2003) · JAMA · doi:10.1001/jama.290.21.2805 · Cited by 1,276 · see citing works
Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1836 · Cited by 1,135 · see citing works
Self-citationCushman, W. C., Ford, C. E., Cutler, J. A., Margolis, K. L., Davis, B. R., Grimm, R. H., Black, H. R., Hamilton, B. P., Holland, J., Nwachuku, C., et al. (2002) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.02045.x · Cited by 979 · see citing works
Self-citationde la Sierra, A., Segura, J., Banegas, J. R., Gorostidi, M., de la Cruz, J. J., Armario, P., Oliveras, A., & Ruilope, L. M. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168948 · Cited by 809 · see citing works
Prevalence of Resistant Hypertension in the United States, 2003–2008
Persell, S. D. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.170308 · Cited by 761 · see citing works
Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008
Egan, B. M., Zhao, Y., Axon, R. N., Brzezinski, W. A., & Ferdinand, K. C. (2011) · Circulation · doi:10.1161/circulationaha.111.030189 · Cited by 599 · see citing works
Cardiovascular prevention and blood pressure reduction
Staessen, J. A., Wang, J., & Thijs, L. (2003) · Journal of Hypertension · doi:10.1097/00004872-200306000-00002 · Cited by 482 · see citing works
Differential Control of Systolic and Diastolic Blood Pressure
Lloyd‐Jones, D. M., Evans, J. C., Larson, M. G., O’Donnell, C. J., Roccella, E. J., & Levy, D. A. (2000) · Hypertension · doi:10.1161/01.hyp.36.4.594 · Cited by 419 · see citing works
PIERDOMENICO, S., LAPENNA, D., BUCCI, A., DITOMMASO, R., DIMASCIO, R., MANENTE, B., CALDARELLA, M., NERI, M., CUCCURULLO, F., & MEZZETTI, A. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.05.014 · Cited by 409 · see citing works
Prognostic Influence of Office and Ambulatory Blood Pressures in Resistant Hypertension
Salles, G. F., Cardoso, C. R. L., & Muxfeldt, E. S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.21.2340 · Cited by 293 · see citing works
Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome
Wang, J.-G., Staessen, J. A., Franklin, S. S., Fagard, R., & Gueyffier, F. (2005) · Hypertension · doi:10.1161/01.hyp.0000165020.14745.79 · Cited by 275 · see citing works
Combination Therapy in Hypertension
Gradman, A. H., Basile, J., Carter, B. L., Bakris, G. L., & on behalf of the American Society of Hypertension Writing Group (2010) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00397.x · Cited by 146 · see citing works
Evaluating Hypertension Control in a Managed Care Setting
Alexander, M., Tekawa, I. S., Hunkeler, E. M., FIREMAN, B. H., Rowell, R., Selby, J. V., Massie, B. M., & Cooper, W. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2673 · Cited by 103 · see citing works
Self-citationChronic renal failure: A cardiovascular risk factor
Fort, J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09906.x · Cited by 95 · see citing works
Hanselin, M. R., Saseen, J. J., Allen, R. R., Marrs, J. C., & Nair, K. V. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.180497 · Cited by 66 · see citing works
Characterization and treatment of resistant hypertension
Pisoni, R., Ahmed, M. I., & Calhoun, D. A. (2009) · Current Cardiology Reports · doi:10.1007/s11886-009-0059-z · Cited by 42 · see citing works
Trends in Time to Confirmation and Recognition of New-Onset Hypertension, 2002–2006
Selby, J. V., Lee, J., Swain, B. E., Tavel, H. M., Ho, P. M., Margolis, K. L., O’Connor, P. J., Fine, L. J., Schmittdiel, J. A., & Magid, D. J. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.153528 · Cited by 31 · see citing works
Self-citationHo, P. M. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.102 · Cited by 17 · see citing works
Self-citationOng, H. T. (2008) · PubMed · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286 · see citing works
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457 · see citing works
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473 · see citing works
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885 · see citing works
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153 · see citing works
Self-citationMartínez-García, M.-A., Capote, F., Campos-Rodríguez, F., Lloberes, P., Díaz de Atauri, M. J., Somoza, M., Masa, J. F., González, M., Sacristán, L., Barbé, F., et al. (2013) · JAMA · doi:10.1001/jama.2013.281250 · Cited by 685 · see citing works
Hundemer, G. L., Curhan, G. C., Yozamp, N., Wang, M., & Vaidya, A. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30367-4 · Cited by 677 · see citing works
Rabi, D. M., McBrien, K. A., Sapir-Pichhadze, R., Nakhla, M., Ahmed, S. B., Dumanski, S. M., Butalia, S., Leung, A. A., Harris, K. C., Cloutier, L., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.02.086 · Cited by 583 · see citing works
Azizi, M., Sanghvi, K., Saxena, M., Gosse, P., Reilly, J. P., Levy, T., Rump, L. C., Persu, A., Basile, J., Bloch, M. J., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00788-1 · Cited by 439 · see citing works
Sim, J. J., Bhandari, S. K., Shi, J., Reynolds, K., Calhoun, D. A., Kalantar-Zadeh, K., & Jacobsen, S. J. (2015) · Kidney International · doi:10.1038/ki.2015.142 · Cited by 238 · see citing works
Muntner, P., Davis, B. R., Cushman, W. C., Bangalore, S., Calhoun, D. A., Pressel, S. L., Black, H. R., Kostis, J. B., Probstfield, J. L., Whelton, P. K., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03850 · Cited by 231 · see citing works
Sim, J. J., Bhandari, S. K., Shi, J., Liu, I. L. A., Calhoun, D. A., McGlynn, E. A., Kalantar-Zadeh, K., & Jacobsen, S. J. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.06.017 · Cited by 206 · see citing works
The double challenge of resistant hypertension and chronic kidney disease
Rossignol, P., Massy, Z. A., Azizi, M., Bakris, G., Ritz, E., Covic, A., Goldsmith, D., Heine, G. H., Jager, K. J., Kanbay, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00418-3 · Cited by 194 · see citing works
Thomas, G., Xie, D., Chen, H.-Y., Anderson, A. H., Appel, L. J., Bodana, S., Brecklin, C. S., Drawz, P., Flack, J. M., Miller, E. R., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06487 · Cited by 190 · see citing works
Resistant Hypertension: Incidence, Prevalence, and Prognosis
Pimenta, E., & Calhoun, D. A. (2012) · Circulation · doi:10.1161/circulationaha.112.097345 · Cited by 188 · see citing works
Prevalence of Apparent Treatment-Resistant Hypertension among Individuals with CKD
Tanner, R. M., Calhoun, D. A., Bell, E. K., Bowling, C. B., Gutiérrez, O. M., Irvin, M. R., Lackland, D. T., Oparil, S., Warnock, D., & Muntner, P. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00550113 · Cited by 168 · see citing works
F. Piepoli, M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9583-6 · Cited by 162 · see citing works
Brinkmann, J., Heusser, K., Schmidt, B. M., Menne, J., Klein, G., Bauersachs, J., Haller, H., Sweep, F. C., Diedrich, A., Jordan, J., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.201186 · Cited by 166 · see citing works
Liu, L., Cao, Q., Guo, Z., & Dai, Q. (2016) · The Journal of Clinical Hypertension · doi:10.1111/jch.12639 · Cited by 160 · see citing works
Irvin, M. R., Booth, J. N., Shimbo, D., Lackland, D. T., Oparil, S., Howard, G., Safford, M. M., Muntner, P., & Calhoun, D. A. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.03.003 · Cited by 146 · see citing works
Hering, D., Marusic, P., Walton, A. S., Lambert, E. A., Krum, H., Narkiewicz, K., Lambert, G. W., Esler, M. D., & Schlaich, M. P. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.03098 · Cited by 142 · see citing works
Resistant Hypertension: A Review of Diagnosis and Management
Vongpatanasin, W. (2014) · JAMA · doi:10.1001/jama.2014.5180 · Cited by 146 · see citing works
Clinical characteristics of patients with resistant hypertension: the RESIST-POL study
Florczak, E., Prejbisz, A., Szwench-Pietrasz, E., Śliwiński, P., Bieleń, P., Klisiewicz, A., Michałowska, I., Warchoł, E., Januszewicz, M., Kała, M., et al. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.32 · Cited by 120 · see citing works
Smith, S. M., Gong, Y., Handberg, E., Messerli, F. H., Bakris, G. L., Ahmed, A., Bavry, A. A., Pepine, C. J., & Cooper-DeHoff, R. M. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000051 · Cited by 115 · see citing works
Drug adherence in hypertension: from methodological issues to cardiovascular outcomes
Hamdidouche, I., Jullien, V., Boutouyrie, P., Billaud, E., Azizi, M., & Laurent, S. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001299 · Cited by 111 · see citing works
Hyperaldosteronism as a Common Cause of Resistant Hypertension
Calhoun, D. A. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-042711-135929 · Cited by 108 · see citing works
Borghi, C., Tubach, F., De Backer, G., Dallongeville, J., Guallar, E., Medina, J., Perk, J., Roy, C., Banegas, J. R., Rodriguez-Artalejo, F., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.05.044 · Cited by 102 · see citing works
Bangalore, S., Fayyad, R., Laskey, R., DeMicco, D. A., Deedwania, P., Kostis, J. B., & Messerli, F. H. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.07.038 · Cited by 93 · see citing works
Tsioufis, C., Kasiakogias, A., Kordalis, A., Dimitriadis, K., Thomopoulos, C., Tsiachris, D., Vasileiou, P., Doumas, M., Makris, T., Papademetriou, V., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000023 · Cited by 91 · see citing works
How to Screen for Non-Adherence to Antihypertensive Therapy
Gupta, P., Patel, P., Horne, R., Buchanan, H., Williams, B., & Tomaszewski, M. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0697-7 · Cited by 84 · see citing works
Improvement of albuminuria after renal denervation
Ott, C., Mahfoud, F., Schmid, A., Ditting, T., Veelken, R., Ewen, S., Ukena, C., Uder, M., Böhm, M., & Schmieder, R. E. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.017 · Cited by 75 · see citing works
Martínez-García, M.-A., Navarro-Soriano, C., Torres, G., Barbé, F., Caballero-Eraso, C., Lloberes, P., Diaz-Cambriles, T., Somoza, M., Masa, J. F., González, M., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11170 · Cited by 74 · see citing works
Diaz, K. M., Booth, J. N., Calhoun, D. A., Irvin, M. R., Howard, G., Safford, M. M., Muntner, P., & Shimbo, D. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03565 · Cited by 72 · see citing works
Smith, S. M., Huo, T., Delia Johnson, B., Bittner, V., Kelsey, S. F., Vido Thompson, D., Noel Bairey Merz, C., Pepine, C. J., & Cooper‐DeHoff, R. M. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000660 · Cited by 69 · see citing works
Sapiña-Beltrán, E., Torres, G., Benitez, I., Fortuna-Gutiérrez, A. M., Márquez, P. P., Masa, J. F., Corral-Peñafiel, J., Drager, L. F., Cabrini, M., Félez, M., et al. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201901-053oc · Cited by 64 · see citing works
Medication adherence and resistant hypertension
Hyman, D. J., & Pavlik, V (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2014.73 · Cited by 61 · see citing works
Shimbo, D., Levitan, E. B., Booth, J. N., Calhoun, D. A., Judd, S. E., Lackland, D. T., Safford, M. M., Oparil, S., & Muntner, P. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835b6be7 · Cited by 60 · see citing works
Wang, C., Xiong, B., & Huang, J. (2016) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2016.02.016 · Cited by 58 · see citing works
Grigoryan, L., Pavlik, V. N., & Hyman, D. J. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.06.004 · Cited by 48 · see citing works
Diagnosis and management of resistant hypertension: state of the art
Wei, F.-F., Zhang, Z.-Y., Huang, Q.-F., & Staessen, J. A. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0006-6 · Cited by 39 · see citing works
Resistant Hypertension and Associated Comorbidities in a <scp>Veterans Affairs</scp> Population
Acharya, T., Tringali, S., Singh, M., & Huang, J. (2014) · The Journal of Clinical Hypertension · doi:10.1111/jch.12410 · Cited by 38 · see citing works
Egan, B. M., Kai, B., Wagner, C. S., Henderson, J. H., Chandler, A. H., & Sinopoli, A. (2016) · The Journal of Clinical Hypertension · doi:10.1111/jch.12773 · Cited by 32 · see citing works
The Prevalence and Prognosis of Resistant Hypertension in Patients with Heart Failure
Jin, C.-N., Liu, M., Sun, J.-P., Fang, F., Wen, Y.-N., Yu, C.-M., & Lee, A. P.-W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114958 · Cited by 29 · see citing works
Resistant Hypertension, Patient Characteristics, and Risk of Stroke
Hung, C.-Y., Wang, K.-Y., Wu, T.-J., Hsieh, Y.-C., Huang, J.-L., Loh, E.-W., & Lin, C.-H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104362 · Cited by 27 · see citing works
Clinical characteristics of resistant hypertension evaluated by ambulatory blood pressure monitoring
Kansui, Y., Matsumura, K., Kida, H., Sakata, S., Ohtsubo, T., Ibaraki, A., & Kitazono, T. (2014) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2013.846360 · Cited by 8 · see citing works
- Authors
- Daugherty, S. L., Powers, J. D., Magid, D. J., Tavel, H. M., Masoudi, F. A., Margolis, K. L., O'Connor, P. J., Selby, J. V., & Ho, P. M.
- Affiliations
- Kaiser Permanente (US)
- From the University of Colorado Denver, Aurora, CO (S.L.D., D.J.M., F.A.M., P.M.H.); Institute for Health Research, Kaiser Permanente of Colorado, Denver, CO (S.L.D., J.D.P., D.J.M., H.M.T., F.A.M., P.M.H.); Denver Health Medical Center, Denver, CO (F.A.M.); Health Partners Research Foundation, Minneapolis, MN (K.L.M., P.J.O.); Kaiser Permanente of Northern California, Division of Research, Oakland, CA (J.V.S.); Patient Centered Outcomes Research Institute, Washington, DC (J.V.S.); and VA Medical...
- ORCID
- Venue
- Circulation
- Published
- 2012-04-03
- Volume
- 125
- Issue
- 13
- Pages
- 1635-1642
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC3343635
- OpenAlex
- W2089259727
- Cited by
- 930
- References
- 30
- Citations by year
- 2026: 41 · 2025: 38 · 2024: 48 · 2023: 55 · 2022: 55 · 2021: 55 · 2020: 65 · 2019: 57 · 2018: 56 · 2017: 63 · 2016: 88 · 2015: 80 · 2014: 104 · 2013: 93 · 2012: 29
- FWCI
- 62.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (U19 HL91179-01, K08HL103776, U19HL091179)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- resistant hypertension, hypertension, incidence, cardiovascular events, prognosis, antihypertensive therapy, uncontrolled hypertension, cardiovascular risk, diabetes mellitus, heart failure, stroke, myocardial infarction, chronic kidney disease
- MeSH terms
- Female, Follow-Up Studies, Humans, Hypertension, Male, Middle Aged, Prognosis, Retrospective Studies, Cohort Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
